REBECCA CAUDILL: Open Payments
NPI 1720774904 · PAINTSVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,359 in 78 payments from 21 companies in 2025. Trend: 2023 $710 · 2024 $1,468 · 2025 $1,359
Food & beverage: $1,359
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 15 | $228 |
| GlaxoSmithKline, LLC. | 9 | $175 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $174 |
| AstraZeneca Pharmaceuticals LP | 4 | $147 |
| ABBVIE INC. | 4 | $82 |
| Verona Pharma, Inc. | 4 | $78 |
| Otsuka America Pharmaceutical, Inc. | 3 | $54 |
| SHIELD THERAPEUTICS INC | 1 | $49 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $45 |
| Lundbeck LLC | 3 | $43 |
Products named: Kerendia, TRELEGY ELLIPTA, CAPLYTA, FARXIGA, REXULTI, Ohtuvayre, UBRELVY, ACCRUFER.
Industry payments across KY — which companies pay providers there.
